EN DE
STOCK COMPARISON

Eli Lilly and vs Roche Holding: Fair Value & Quality

Both stocks run through our valuation models. Here is how Eli Lilly and (LLY) and Roche Holding (RO) compare, as of Sep 5, 2026.

As of Sep 5, 2026, Fair Value Calculator sees Roche Holding as the less overvalued of the two: Eli Lilly and trades at $1,160 versus a fair value of $389 (-66%), while Roche Holding trades at CHF 364 versus CHF 307 (-16%).
Eli Lilly and
LLY · USD · Health Care
-66%
upside to fair value
overvalued
Price$1,160
Fair Value$389
Quality69/100
Roche Holding
RO.SW · CHF · Health Care
-16%
upside to fair value
overvalued
PriceCHF 364
Fair ValueCHF 307
Quality75/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Eli Lilly andRoche Holding
Valuation
42.2×P/E (TTM)20.8×
14.67×P/S (TTM)5.17×
39.94×P/B9.69×
30.2×EV/EBITDA14.5×
1.54×PEG1.46×
−66.4%Fair value upside−15.8%
0.5%Dividend yield2.7%
$6.23Dividend per shareCHF 9.80
Profitability
49%Operating margin30%
1.42×EBIT margin trend (5Y)1.03×
107%Return on equity37%
21%Return on assets13%
Growth
56%Revenue growth (YoY)-0%
31.7%Avg. growth/yr (3Y)-2.2%
21.6%Avg. growth/yr (5Y)1.1%
+29.3%Value creation/yr+2.5%
Balance & size
37.3×Interest coverage (EBIT/interest)14.3×
1.54×Debt / equity0.81×
$1.1TMarket cap$328B
mixedGrowth qualityweak

Even match: 8 to 8 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Eli Lilly andof which business quality 65 · market factors 78 Roche Holdingof which business quality 73 · market factors 75
ProfitabilityMargins and returns on capital today
85
77
Quality GrowthAre margins and returns improving?
86
61
CashflowEarnings quality: real cash, not paper profit
51
81
Fin. StrengthBalance sheet, leverage, solvency risk
53
63
InvestmentDisciplined investing over empire-building
15
74
Low VolatilityCalm price path (market factor)
77
89
MomentumPrice trend over the last 3–12 months (market factor)
71
61
52W MomentumDistance to the 52-week high (market factor)
92
83
Net IssuanceBuybacks instead of dilution
93
81

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyEli Lilly andPrice $1,160Roche HoldingPrice CHF 364
DCF Models-71%below the price$334-27%below the priceCHF 264
Earnings-Based-79%below the price$239-43%below the priceCHF 209
Dividend Discount-90%below the price$115-58%below the priceCHF 152
Multiples-69%below the price$358-15%close to the priceCHF 311
Asset-Based-98%below the price$19.94-92%below the priceCHF 28.20
Growth DCF-84%below the price$187-35%below the priceCHF 237
Economic Profit-70%below the price$347-51%below the priceCHF 177
Growth Earnings-68%below the price$375-24%below the priceCHF 277
Minimum-98%below the price$19.94-92%below the priceCHF 28.20
Maximum-68%below the price$375-15%close to the priceCHF 311
Median-75%below the price$287-39%below the priceCHF 223
Geometric mean-84%below the price$189-52%below the priceCHF 174

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

Eli Lilly and: 26 of 26 models see the stock below the current price.

Roche Holding: 23 of 25 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Eli Lilly and
Bear $216Fair Value $389Bull $582
$1,160 = current price (white tick)
Roche Holding
Bear CHF 195Fair Value CHF 307Bull CHF 441
CHF 364 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Eli Lilly and · Health Care

Quality score69 · Top 25%
Fair value upside-66% · bottom 25%

Roche Holding · Health Care

Quality score75 · Top 25%
Fair value upside-16% · above median

Bottom line

As of Sep 5, 2026, Fair Value Calculator sees Roche Holding as the less overvalued of the two: Eli Lilly and trades at $1,160 versus a fair value of $389 (-66%), while Roche Holding trades at CHF 364 versus CHF 307 (-16%).

Roche Holding has the higher quality score (75/100).

See the full analysis →
Eli Lilly and · Roche Holding

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Eli Lilly and

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupMerck & Company vs UnitedHealth Group

Related to Roche Holding

AstraZeneca vs UnitedHealth GroupThermo Fisher Scientific vs UnitedHealth GroupAmgen vs UnitedHealth GroupAbbott Laboratories vs UnitedHealth Group
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.